All In MedTech

FDA Clearance Tracker · P780012

HAVAB

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Jan 19, 1979 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Jan 19, 1979

Approved (reclassified)

Time to decision

77 days

Received Nov 3, 1978. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class II

The decision

FDA number
P780012
Device name
HAVAB
Applicant location
Abbott Park, IL
Received
Nov 3, 1978
Decided
Jan 19, 1979
Decision
Approved (reclassified)
Supplements
14 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class II
Regulation
21 CFR 866.3310

Every decision under product code LOL

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code LOL (Hepatitis a test (antibody and igm antibody)).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Abbott Laboratories

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.